Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Affibody

  • You have access
    Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
    Ahmet Krasniqi, Matthias D’Huyvetter, Nick Devoogdt, Fredrik Y. Frejd, Jens Sörensen, Anna Orlova, Marleen Keyaerts and Vladimir Tolmachev
    Journal of Nuclear Medicine June 1, 2018, 59 (6) 885-891; DOI: https://doi.org/10.2967/jnumed.117.199901
  • You have access
    Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients
    Mattias Sandström, Karolina Lindskog, Irina Velikyan, Anders Wennborg, Joachim Feldwisch, Dan Sandberg, Vladimir Tolmachev, Anna Orlova, Jens Sörensen, Jörgen Carlsson, Henrik Lindman and Mark Lubberink
    Journal of Nuclear Medicine June 1, 2016, 57 (6) 867-871; DOI: https://doi.org/10.2967/jnumed.115.169342
  • You have access
    Feasibility of Affibody-Based Bioorthogonal Chemistry–Mediated Radionuclide Pretargeting
    Mohamed Altai, Anna Perols, Maria Tsourma, Bogdan Mitran, Hadis Honarvar, Marc Robillard, Raffaella Rossin, Wolter ten Hoeve, Mark Lubberink, Anna Orlova, Amelie Eriksson Karlström and Vladimir Tolmachev
    Journal of Nuclear Medicine March 1, 2016, 57 (3) 431-436; DOI: https://doi.org/10.2967/jnumed.115.162248
  • You have access
    First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111In-ABY-025 Affibody Molecule
    Jens Sörensen, Dan Sandberg, Mattias Sandström, Anders Wennborg, Joachim Feldwisch, Vladimir Tolmachev, Gunnar Åström, Mark Lubberink, Ulrike Garske-Román, Jörgen Carlsson and Henrik Lindman
    Journal of Nuclear Medicine May 1, 2014, 55 (5) 730-735; DOI: https://doi.org/10.2967/jnumed.113.131243
SNMMI

© 2025 SNMMI

Powered by HighWire